跳至主要内容
临床试验/NCT02027467
NCT02027467已完成不适用

Assessment of the Effect of StemAlive® Herbal Supplement on the Levels of Circulating Hematopoietic Stem Cells in Human Volunteers

Vedic Lifesciences Pvt. Ltd.1 个研究点 分布在 1 个国家目标入组 23 人开始时间: 2014年2月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
23
试验地点
1
主要终点
CD45+

研究概览

简要总结

Combination of various herbs is known to promote mobilization of hematopoietic stem cells. Hence the current study has been intended to study the effect of Stem Alive® on mobilization of stem cells. Stem Alive® include ingredients like green tea, ashwagandha, etc which are known to be used as traditional medicine. They are also tested qualitatively in academic and nutritional science research centers throughout the world and which substantially according to those studies stimulate the augmented availability of circulating hematopoietic cells. This study is projected to investigate the mobilization of stem cells on healthy human volunteers.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
盲法
Double (Participant, Investigator)

入排标准

年龄范围
18 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者
是

入选标准

  • •Healthy Male and Female Volunteers
  • •Willing to sign Informed Consent Form

排除标准

  • •SGOT and Serum Creatinine values twice the upper limit of normal
  • •Volunteers who smoke / consume alcohol / take recreational drugs
  • •Fever or Flu in the last one week of screening
  • •History of Gastric or Duodenal Ulcer
  • •Volunteers on vitamins, nutritional or herbal products since last one month
  • •Pregnant, Breast feeding and Lactating women
  • •Volunteers taking antibiotic, NSAIDS, anti-inflammatory within last 7 days
  • •Allergic to ingredients of test product
  • •Any co morbid or systemic condition or immunocompromised state making volunteer unfit for participation.
  • •Volunteers deemed unfit for the study by the Investigator

研究组 & 干预措施

StemAlive®

Experimental

Stem Alive® includes ingredients like green tea, ashwagandha. Dose: 3 capsules twice daily to be taken orally for 14 days.

干预措施: StemAlive® (Dietary Supplement)

Placebo

Placebo Comparator

Matching placebo capsules (for StemAlive®) containing polyethylene glycol, rice powder and magnesium stearate. Dose: 3 capsules twice daily to be taken orally for 14 days.

干预措施: Placebo (For StemAlive®) (Dietary Supplement)

结局指标

主要结局

CD45+

时间窗: Day 0, Day 1, Day 2, Day 7, Day 12 and Day 14

CD34+

时间窗: Day 0, Day 1, Day 2, Day 7, Day 12 and Day 14

CD133+

时间窗: Day 0, Day 1, Day 2, Day 7, Day 12 and Day 14

次要结局

未报告次要终点

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

已完成
不适用
Safety and efficacy of herbal supplements in prediabetic and mild to moderate hyperlipidemic subjects.
CTRI/2012/05/002678Olive Lifesciences Pvt Ltd40
已完成
不适用
Safety and Efficacy Study of Herbal Supplements in Prediabetic and Mild to Moderate Hyperlipidemic PatientsHyperlipidemiaPrediabetes
NCT01680211Olive Lifesciences Pvt Ltd40
终止
不适用
Etoposide, Filgrastim, and Plerixafor in Improving Stem Cell Mobilization in Treating Patients With Non-Hodgkin LymphomaAdult Acute Lymphoblastic Leukemia in RemissionAdult Grade III Lymphomatoid GranulomatosisAdult Nasal Type Extranodal NK/T-cell LymphomaAnaplastic Large Cell LymphomaAngioimmunoblastic T-cell LymphomaHepatosplenic T-cell LymphomaCutaneous B-cell Non-Hodgkin LymphomaExtranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid TissueNodal Marginal Zone B-cell LymphomaNoncutaneous Extranodal LymphomaPeripheral T-cell LymphomaRecurrent Adult Burkitt LymphomaRecurrent Adult Diffuse Large Cell LymphomaRecurrent Adult Diffuse Mixed Cell LymphomaRecurrent Adult Diffuse Small Cleaved Cell LymphomaRecurrent Adult Grade III Lymphomatoid GranulomatosisRecurrent Adult Immunoblastic Large Cell LymphomaRecurrent Adult Lymphoblastic LymphomaRecurrent Adult T-cell Leukemia/LymphomaRecurrent Cutaneous T-cell Non-Hodgkin LymphomaRecurrent Grade 1 Follicular LymphomaRecurrent Grade 2 Follicular LymphomaRecurrent Grade 3 Follicular LymphomaRecurrent Mantle Cell LymphomaRecurrent Marginal Zone LymphomaRecurrent Mycosis Fungoides/Sezary SyndromeRecurrent Small Lymphocytic LymphomaRefractory Chronic Lymphocytic LeukemiaRefractory Hairy Cell LeukemiaSmall Intestine LymphomaSplenic Marginal Zone LymphomaT-cell Large Granular Lymphocyte LeukemiaTesticular LymphomaWaldenström Macroglobulinemia
NCT01408043Case Comprehensive Cancer Center25
尚未招募
2 期
Studying the Effectiveness of Herbal Extract Blend for Stress and related conditions.
CTRI/2023/09/057801isarga Biotech Pvt. Ltd.
已完成
不适用
Efficacy and Immunomodulator Impact of Herbal Combination on COVID-19 Patients RecoveryCOVID 19
NCT06636760Indonesia University66